BJM: Wakefield planned to profit from vaccine scare

Last week we reported the British Medical Journal's conclusion that Andrew Wakefield's now-infamous study linking childhood vaccines to autism was "an elaborate fraud." In a follow-up editorial, the Journal alleges Wakefield's motive for faking his study was the potential for huge financial gain.

Author Brian Deer says Wakefield planned to make big money developing and marketing his own "safer" vaccines--as well as diagnostic test kits--after causing the public distrust of traditional vaccines. Deer notes that Wakefield discussed deals with medical school managers before his study was even complete. The former doctor "planned secret businesses intended to make huge sums of money, in Britain and America, from his now-discredited allegations," the BMJ said in a release.

Even though Wakefield's 1998 study has been discredited, many vaccine doubters continue to avoid childhood vaccines, fearing they can lead to autism. Wakefield was banned from practicing medicine in his home country after a U.K. panel of medical experts castigated him for professional misconduct.

- here's the BMJ report
- read the Discovery News article

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.